Draft genome sequence of Stenotrophomonas maltophilia strain TUM26315, a bloodstream isolate resistant to cefiderocol and to aztreonam combined with ceftazidime-avibactam

ABSTRACT  Here, we report the draft genome sequence of Stenotrophomonas maltophilia TUM26315, which exhibits resistance to cefiderocol and to aztreonam combined with ceftazidime-avibactam, despite no prior exposure. The isolate belonged to genomic group 6 and carried blaL1B and blaL2B β-lactamase genes. It also had a frameshift mutation in the cirA gene.

• Publication year

  2025

• Venue

  Microbiology Resource Announcements

• Publication date

  2025-10-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/mra.00949-25PMID 41165115PMCID 12697194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DFAST_QC: quality assessment and taxonomic identification tool for prokaryotic Genomes

  2024cited by this paper
• Cefiderocol susceptibility of 146 Stenotrophomonas maltophilia strains clinically isolated from blood in two Japanese hospitals over a 10-year period

  2024cited by this paper
• Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia: a systematic review and meta-analysis.

  2023cited by this paper
• Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance

  2022cited by this paper
• Evolution of cefiderocol resistance in Stenotrophomonas maltophilia using in vitro serial passage techniques

  2022cited by this paper
• OUP accepted manuscript

  2022cited by this paper
• Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models.

  2021cited by this paper
• The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia

  2019cited by this paper
• Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States

  2019cited by this paper
• In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria

  2019cited by this paper
• In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016

  2017cited by this paper
• In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study)

  2017cited by this paper
• DFAST and DAGA: web-based integrated genome annotation tools and resources

  2016cited by this paper
• Trimmomatic: a flexible trimmer for Illumina sequence data

  2014cited by this paper
• SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing

  2012cited by this paper
• Plasmid Location and Molecular Heterogeneity of the L1 and L2 β-Lactamase Genes of Stenotrophomonas maltophilia

  2001cited by this paper
• Basic local alignment search tool.

  1990cited by this paper

• No citing papers are available for this paper.